Left Atrial Appendage (LAA) Closure-Device Disengagement as a Serious Complication and How it Can Be Easily Removed
Abstract
A stroke attack in the brainstem area as a serious complication of atrial fibrillation (AF) in a 51 year old woman with known paroxysmal AF (CHADS² score 3) was treated with LAA occlusion procedure after the complication of arterial bleeding secondary to anticoagulation therapy. LAA closure device embolisation was developed following the LAA occlusion procedure. The device was located and removed successfully from the systemic circulation. Turkish Anahtar Kelimeler: Atriyal fibrilasyon, LAA oklüzyonu, materyal embolizasyonu 51 yaşında, paroksismal atriyal fibrilasyon (CHADS² skor 3) teşhisi olan bayan hastada, AF'ye bağlı ciddi bir komplikasyon olarak beyin sapı bölgesinden gelişen strok atağı, ilk olarak uygulanan antikoagülasyon tedavisine sekonder kanama gelişince, LAA oklüzyon prosedürü uygulanarak tedavi edildi. LAA oklüzyon prosedürünü takiben hastada LAA oklüzyon materyali embolizasyonu gelişmesi üzerine, sistemik dolaşımdaki yeri tespit edildikten sonra oklüzyon materyali başarıyla çıkartıldı.
References
- Ostermayer SH, Reisman M, Kramer PH, Matthews RV, Gray WA, Block PC, et al. Percutaneous left atrial appendage transcatheter oc- clusion [PLAATO system] to prevent stroke in high risk patients with non rheumatic atrial fibrillation: results from the international multi- center feasibility trials. J Am Coll Cardiol 2005;46:9-14. [CrossRef]
- Sick PB, Schuler G, Hauptmann KE, Grube E, Yakubov S, Turi ZG, et al. Initial worldwide experience with the WATCHMAN left atri- al appendage system for stroke prevention in atrial fibrillation. J Am Coll Cardiol 2007;49:1490-5. [CrossRef]
- Holmes DR, Reddy VY, Turi ZG. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomized noninferiority trial. Lancet 2009;374:534-42. [CrossRef]
- Park JW, Bethencourt A, Sievert H. Left atrial appendage closure with amplatzer cardiac plug in atrial fibrillation - Initial European ex- perience. Catheter Cardiovasc Interv 2011;77:700-6. [CrossRef] 325 2012; 29: 324-5 Burgazlı et al.
- How to Deal LAA Closure Device Disengagement
Left Atrial Appendage (LAA) Closure-Device Disengagement as a Serious Complication and How it Can Be Easily Removed
Abstract
References
- Ostermayer SH, Reisman M, Kramer PH, Matthews RV, Gray WA, Block PC, et al. Percutaneous left atrial appendage transcatheter oc- clusion [PLAATO system] to prevent stroke in high risk patients with non rheumatic atrial fibrillation: results from the international multi- center feasibility trials. J Am Coll Cardiol 2005;46:9-14. [CrossRef]
- Sick PB, Schuler G, Hauptmann KE, Grube E, Yakubov S, Turi ZG, et al. Initial worldwide experience with the WATCHMAN left atri- al appendage system for stroke prevention in atrial fibrillation. J Am Coll Cardiol 2007;49:1490-5. [CrossRef]
- Holmes DR, Reddy VY, Turi ZG. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomized noninferiority trial. Lancet 2009;374:534-42. [CrossRef]
- Park JW, Bethencourt A, Sievert H. Left atrial appendage closure with amplatzer cardiac plug in atrial fibrillation - Initial European ex- perience. Catheter Cardiovasc Interv 2011;77:700-6. [CrossRef] 325 2012; 29: 324-5 Burgazlı et al.
- How to Deal LAA Closure Device Disengagement
Details
| Primary Language | English |
|---|---|
| Subjects | Health Care Administration |
| Journal Section | Articles |
| Authors | |
| Publication Date | March 1, 2012 |
| Published in Issue | Year 2012 |